LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)
Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –
LifeStance Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
LifeStance Health's total debt was $270.02M at Sep 30, 2026. For fiscal 2025 it was $280.43M, down 2.3% from the year before. The highest annual figure on record is $366.27M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $280.43M | -2.3% |
| FY2024 | Dec 31, 2024 | $287.04M | +1.4% |
| FY2023 | Dec 31, 2023 | $283.21M | +24.5% |
| FY2022 | Dec 31, 2022 | $227.42M | +43.3% |
| FY2021 | Dec 31, 2021 | $158.74M | -56.7% |
| FY2020 | Dec 31, 2020 | $366.27M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $270.02M | -4.3% |
| Q2 FY2026 | Jun 30, 2026 | $273.49M | -3.6% |
| Q1 FY2026 | Mar 31, 2026 | $280.58M | -1.7% |
| Q4 FY2025 | Dec 31, 2025 | $280.43M | -2.3% |
| Q3 FY2025 | Sep 30, 2025 | $282.08M | +0.0% |
| Q2 FY2025 | Jun 30, 2025 | $283.73M | +0.5% |
| Q1 FY2025 | Mar 31, 2025 | $285.39M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $287.04M | +1.4% |
| Q3 FY2024 | Sep 30, 2024 | $281.98M | +12.4% |
| Q2 FY2024 | Jun 30, 2024 | $282.38M | +12.4% |
| Q1 FY2024 | Mar 31, 2024 | $282.80M | +24.5% |
| Q4 FY2023 | Dec 31, 2023 | $283.21M | +24.5% |
| Q3 FY2023 | Sep 30, 2023 | $250.97M | +17.2% |
| Q2 FY2023 | Jun 30, 2023 | $251.31M | +22.7% |
| Q1 FY2023 | Mar 31, 2023 | $227.11M | +27.1% |
| Q4 FY2022 | Dec 31, 2022 | $227.42M | +43.3% |
| Q3 FY2022 | Sep 30, 2022 | $214.19M | +34.9% |
| Q2 FY2022 | Jun 30, 2022 | $204.86M | +29.1% |
| Q1 FY2022 | Mar 31, 2022 | $178.70M | -51.2% |
| Q4 FY2021 | Dec 31, 2021 | $158.74M | – |
| Q3 FY2021 | Sep 30, 2021 | $158.77M | – |
| Q2 FY2021 | Jun 30, 2021 | $158.69M | – |
| Q4 FY2020 | Dec 31, 2020 | $366.27M | – |
See a number that looks wrong?